Covid Testing Company Says PCR Tests Are Effective Against New Covid Variant – Barrons

Qiagen closed higher Friday after the diagnostics company reaffirmed the efficacy of its PCR tests against the new Covid variant which scrambled stock markets on Friday.

The stock closed 3.5% higher at $56.47.

Qiagen (ticker: QGEN) said it assessed its SARS-CoV-2 PCR tests against the new genetic mutations of the variant, known by its scientific…